
|Articles|November 26, 2007
Alcon makes final push for WaveLight
Alcon has received all the required regulatory clearances relating to its tender offer for WaveLight AG.
Advertisement
Alcon has received all the required regulatory clearances relating to its tender offer for WaveLight AG.
Upon settlement of all tendered shares, Alcon will own 77.4% of the outstanding WaveLight shares and shareholders who tendered their shares under the offer will automatically receive payment.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times Europe
1
IGS 2026: Navigating MIGS and other modern glaucoma procedures
2
IGS 2026: The expanding role of artificial intelligence in ophthalmology
3
IGS 2026: Current clinical perspectives on optic disc drusen
4
IGS 2026: Clinical pearls for detecting pre-perimetric glaucoma
5





























